Physician profile
Robert Witte
NPI 1700312162
$4,638.76
in general payments reported to CMS, 2019-2025
27 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $736 · 2022: $1,010 · 2023: $866 · 2024: $1,558 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,892.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $792.09 | 2021-2024 | Farxiga, Brilinta, Wainua |
| Merck Sharp & Dohme LLC | $533.80 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $478.12 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $403.67 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $385.34 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.81 | 2021-2024 | Jardiance |
| Boston Scientific Corporation | $230.83 | 2022-2025 | Watchman Flx, Watchman Access System, Watchman |
| Pfizer INC. | $172.78 | 2021-2024 | |
| Atricure, INC. | $169.47 | 2025 | Synergy Ablation System |
| Novo Nordisk INC | $162.27 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Lexicon Pharmaceuticals, INC. | $157.19 | 2024 | |
| Amgen INC. | $155.36 | 2021-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals International, Plc | $136.48 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, Ltd. | $129.30 | 2023 | Arcalyst |
| Heartflow, INC. | $91.85 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $65.77 | 2021-2024 | Nexletol |
| Abiomed | $52.05 | 2024-2025 | Impella |
| Kestra Medical Technology Services, INC. | $48.46 | 2024 | Assure Wcd |
| Amarin Pharma, INC. | $43.04 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.17 | 2021-2025 | Lifevest |
| Philips North America LLC | $29.09 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $25.60 | 2021 | |
| Medtronic, INC. | $23.61 | 2025 | Mosaic |
| Chiesi USA, INC. | $23.00 | 2023 | Cleviprex, Kengreal |
| Inari Medical, INC. | $22.45 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lsi Solutions INC | $20.56 | 2025 | Cor-Knot |
| Bayer Healthcare Pharmaceuticals INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Witte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.